---
meta-og:type: article
---

# 人格解体

[◀返回](./home.md)

**人格解体** 或 **人格解体化**（有时缩写为 **DP**）在医学上被认定为一种体验，感觉自己从自己的思想、身体或行动中分离出来，就像是一个外部观察者一样。[\[1\]](#cite_note-DSM5Glossary-1)[\[2\]](#cite_note-ICD-11-depersonalization-derealization-disorder-2)[\[3\]](#cite_note-:1-3)[\[4\]](#cite_note-:4-4) 在这种状态下，受影响的人可能会觉得自己是在“[自动驾驶](/药效/躯体自主.md)”，并且感觉这个世界缺乏意义。[\[4\]](#cite_note-:4-4)[\[5\]](#cite_note-:2-5) 经历人格解体的个体感到与自我的各个方面分离，包括感觉（例如，“我知道我有感觉，但我感觉不到它们”）、[\[6\]](#cite_note-:3-6) 思想（例如，“我的想法感觉不像是我自己的”）[\[7\]](#cite_note-:5-7)，以及感官（例如，触觉、饥饿、口渴、性欲）。[\[3\]](#cite_note-:1-3)[\[8\]](#cite_note-:0-8)[\[9\]](#cite_note-:6-9) 这可能会让使用者感到很苦恼呢，因为失去了自我是思想和行动起源的感觉，他们可能会变得迷失方向。

人们暂时陷入这种状态是完全正常的哦，[\[10\]](#cite_note-:8-10) 甚至经常是在没有意识到的情况下发生的。例如，许多人经常提到，在压力大的情况下或者在执行单调的常规任务（如开车）时，他们会进入一种分离的自动驾驶状态。

值得注意的是，这种精神状态通常与 [现实解体](/药效/现实解体.md) 相关联并同时发生。虽然人格解体是自我感中不真实的主观体验，但现实解体是对外部世界不真实的感知哦。[\[2\]](#cite_note-ICD-11-depersonalization-derealization-disorder-2)[\[3\]](#cite_note-:1-3)[\[5\]](#cite_note-:2-5)[\[8\]](#cite_note-:0-8)[\[9\]](#cite_note-:6-9)

人格解体通常伴随着其他并发效应，如 [焦虑](/药效/焦虑.md)、[\[3\]](#cite_note-:1-3)[\[6\]](#cite_note-:3-6) [抑郁](/药效/抑郁.md)、[\[6\]](#cite_note-:3-6) [时间扭曲](/药效/时间缩放.md) [\[7\]](#cite_note-:5-7) 和 [现实解体](/药效/现实解体.md)。[\[8\]](#cite_note-:0-8)[\[11\]](#cite_note-:7-11) 它最常在 [中等](/文档/药物剂量分类.md#中等) [剂量](/文档/给药剂量.md) 的 [解离剂](/文档/药物分类/解离剂.md) 影响下被诱发，如 [氯胺酮](/药物/氯胺酮.md)、[\[10\]](#cite_note-:8-10) [PCP](/药物/PCP.md)[\[12\]](#cite_note-12)[\[13\]](#cite_note-13) 和 [右美沙芬](/药物/右美沙芬.md)。然而，它也可能在 [大麻](/药物/大麻.md)、[\[10\]](#cite_note-:8-10)[\[11\]](#cite_note-:7-11)[\[14\]](#cite_note-14) [迷幻剂](/文档/药物分类/迷幻剂.md) 的影响下发生，[\[10\]](#cite_note-:8-10) 并且在较小程度上可能发生在 [抑制剂](/文档/药物分类/抑制剂.md)[\[15\]](#cite_note-15)[\[16\]](#cite_note-16) 和 [SSRI类药物](/文档/药物分类/神经递质再摄取抑制剂.md)[\[10\]](#cite_note-:8-10) 的 [戒断](/文档/药物戒断反应.md) 症状期间。

## 目录

* [1 分析](#分析)
* [2 精神活性物质](#精神活性物质)
* [3 体验报告](#体验报告)
* [4 另见](#另见)
* [5 外部链接](#外部链接)
* [6 参考文献](#参考文献)

### 分析

在精神病学中，清醒时出现的慢性人格解体被认定为“人格解体/现实解体障碍”，并被 DSM-5 和 ICD-11 归类为单一的解离性障碍。[\[2\]](#cite_note-ICD-11-depersonalization-derealization-disorder-2)[\[8\]](#cite_note-:0-8)

持续数小时至数天的暂时性人格解体/现实解体症状在一般人群中很常见。大约有一半的成年人在一生中至少经历过一次这种效应，该障碍的性别比例为 1:1。[\[8\]](#cite_note-:0-8) 慢性人格解体在经历过严重创伤或长期压力和焦虑的个体中更为常见。慢性现实解体和人格解体的症状在一般人群中很常见，终生患病率高达 26-74%，在创伤事件发生时为 31–66%。[\[17\]](#cite_note-17)

在 [身份改变](/药效/自我膨胀.md) 效应的背景下，相对于 [统一与互联](/药效/超个人效应.md) 状态，人格解体可以被视为处于身份光谱的另一端。这是因为，在人格解体期间，一个人感觉并将自己的身份归因于“无”，产生一种没有自我的感觉。然而，在统一与互联的状态下，一个人感觉并将自己的身份归因于“万物”，产生一种整个存在都是自我的感觉呢。

### 体验报告

描述此效应的坊间报告可以在我们的 [体验报告索引](/文档/体验报告索引.md) 中找到，包括：

* [报告/psychounautwiki/Experience: 1 tab 1P-LSD (oral) - Finding myself within the forest](报告/psychounautwiki/Experience:_1_tab_1P-LSD_(oral)_-_Finding_myself_within_the_forest)
* [报告/psychounautwiki/Experience:200 mg of MXP + N2O:20 chargers](报告/psychounautwiki/Experience:200_mg_of_MXP_%2B_N2O:20_chargers)
* [报告/psychounautwiki/Experience:260 mg Ketamine (insufflated) - Lost in Paisley](报告/psychounautwiki/Experience:260_mg_Ketamine_(insufflated)_-_Lost_in_Paisley)
* [报告/psychounautwiki/Experience:3-MEO-PCMo (420mg) - Trip Report](报告/psychounautwiki/Experience:3-MEO-PCMo_(420mg)_-_Trip_Report)
* [报告/psychounautwiki/Experience:337mg DMT fumarate - A Day With DMT](报告/psychounautwiki/Experience:337mg_DMT_fumarate_-_A_Day_With_DMT)
* [报告/psychounautwiki/Experience:535mg - My First DXM Trip](报告/psychounautwiki/Experience:535mg_-_My_First_DXM_Trip)
* [报告/psychounautwiki/Experience:LSD (400ug, Oral) - An afternoon in "a" garden](报告/psychounautwiki/Experience:LSD_(400ug,_Oral)_-_An_afternoon_in_%22a%22_garden)
* [报告/psychounautwiki/Experience:MXE: 37.5 mg - Calm and Cloudy Bliss](报告/psychounautwiki/Experience:MXE:_37.5_mg_-_Calm_and_Cloudy_Bliss)
* [报告/psychounautwiki/Experience:Nitrous oxide (approx. 50 puffs) - ~50 puffs nitrous oxide](报告/psychounautwiki/Experience:Nitrous_oxide_(approx._50_puffs)_-_~50_puffs_nitrous_oxide)
* [报告/psychounautwiki/Experience:Unknown Dose DOC (Insufflated) - Overdosing and Terifying Ego Death](报告/psychounautwiki/Experience:Unknown_Dose_DOC_(Insufflated)_-_Overdosing_and_Terifying_Ego_Death)
* [报告/psychounautwiki/Experience:~150mg MDA(oral) - a case of mistaken identity](报告/psychounautwiki/Experience:~150mg_MDA(oral)_-_a_case_of_mistaken_identity)

### 另见

* [负责任的用药](/文档/负责任的用药索引页.md)
* [现实解体](/药效/现实解体.md)
* [主观效应索引](/药效/home.md)
* [迷幻剂 - 主观效应](/文档/药物分类/迷幻剂.md#主观效应)
* [解离剂 - 主观效应](/文档/药物分类/解离剂.md#主观效应)

### 外部链接

* [Depersonalization (Wikipedia)](http://en.wikipedia.org/wiki/Depersonalization)

### 参考文献

1. [↑](#cite_ref-DSM5Glossary_1-0) "Glossary of Technical Terms". *Diagnostic and statistical manual of mental disorders (5th ed.)*: 818–20\. 2013\. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10\.1176/appi.books.9780890425596\.GlossaryofTechnicalTerms](//doi.org/10.1176%2Fappi.books.9780890425596.GlossaryofTechnicalTerms). 
2. ↑ [2\.0](#cite_ref-ICD-11-depersonalization-derealization-disorder_2-0) [2\.1](#cite_ref-ICD-11-depersonalization-derealization-disorder_2-1) [2\.2](#cite_ref-ICD-11-depersonalization-derealization-disorder_2-2) ["Depersonalization\-derealization disorder"](https://icd.who.int/browse11/l-m/en#/http://id.who.int/icd/entity/253124068). *International statistical classification of diseases and related health problems (11th ed.)*. 2022. Retrieved 20 May 2022. 
3. ↑ [3\.0](#cite_ref-:1_3-0) [3\.1](#cite_ref-:1_3-1) [3\.2](#cite_ref-:1_3-2) [3\.3](#cite_ref-:1_3-3) Kolev, O. I., Georgieva\-Zhostova, S. O., Berthoz, A. (28 January 2014\). ["Anxiety Changes Depersonalization and Derealization Symptoms in Vestibular Patients"](https://www.hindawi.com/journals/bn/2014/847054/). *Behavioural Neurology*. **2014**: e847054\. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10\.1155/2014/847054](//doi.org/10.1155%2F2014%2F847054). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number "wikipedia:International Standard Serial Number") [0953\-4180](//www.worldcat.org/issn/0953-4180). 
4. ↑ [4\.0](#cite_ref-:4_4-0) [4\.1](#cite_ref-:4_4-1) Sierra, M., Senior, C., Dalton, J., McDonough, M., Bond, A., Phillips, M. L., O’Dwyer, A. M., David, A. S. (1 September 2002\). ["Autonomic Response in Depersonalization Disorder"](http://archpsyc.jamanetwork.com/article.aspx?doi=10.1001/archpsyc.59.9.833). *Archives of General Psychiatry*. **59** (9\): 833\. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10\.1001/archpsyc.59\.9\.833](//doi.org/10.1001%2Farchpsyc.59.9.833). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number "wikipedia:International Standard Serial Number") [0003\-990X](//www.worldcat.org/issn/0003-990X). 
5. ↑ [5\.0](#cite_ref-:2_5-0) [5\.1](#cite_ref-:2_5-1) Radovic, F., Radovic, S. (2002\). ["Feelings of Unreality: A Conceptual and Phenomenological Analysis of the Language of Depersonalization"](http://muse.jhu.edu/content/crossref/journals/philosophy_psychiatry_and_psychology/v009/9.3radovic01.html). *Philosophy, Psychiatry, \& Psychology*. **9** (3\): 271–279\. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10\.1353/ppp.2003\.0048](//doi.org/10.1353%2Fppp.2003.0048). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number "wikipedia:International Standard Serial Number") [1086\-3303](//www.worldcat.org/issn/1086-3303). 
6. ↑ [6\.0](#cite_ref-:3_6-0) [6\.1](#cite_ref-:3_6-1) [6\.2](#cite_ref-:3_6-2) Phillips, M. L., Medford, N., Senior, C., Bullmore, E. T., Suckling, J., Brammer, M. J., Andrew, C., Sierra, M., Williams, S. C. R., David, A. S. (December 2001\). ["Depersonalization disorder: thinking without feeling"](https://linkinghub.elsevier.com/retrieve/pii/S0925492701001196). *Psychiatry Research: Neuroimaging*. **108** (3\): 145–160\. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10\.1016/S0925\-4927(01\)00119\-6](//doi.org/10.1016%2FS0925-4927%2801%2900119-6). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number "wikipedia:International Standard Serial Number") [0925\-4927](//www.worldcat.org/issn/0925-4927). 
7. ↑ [7\.0](#cite_ref-:5_7-0) [7\.1](#cite_ref-:5_7-1) Melges, F. T. (1 September 1970\). ["Temporal Disintegration and Depersonalization During Marihuana Intoxication"](http://archpsyc.jamanetwork.com/article.aspx?doi=10.1001/archpsyc.1970.01750030012003). *Archives of General Psychiatry*. **23** (3\): 204\. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10\.1001/archpsyc.1970\.01750030012003](//doi.org/10.1001%2Farchpsyc.1970.01750030012003). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number "wikipedia:International Standard Serial Number") [0003\-990X](//www.worldcat.org/issn/0003-990X). 
8. ↑ [8\.0](#cite_ref-:0_8-0) [8\.1](#cite_ref-:0_8-1) [8\.2](#cite_ref-:0_8-2) [8\.3](#cite_ref-:0_8-3) [8\.4](#cite_ref-:0_8-4) [*Dissociative Disorders*](https://doi.org/10.1176/appi.books.9780890425596.dsm08). *Diagnostic and statistical manual of mental disorders (5th ed.)* (Fifth Edition ed.). American Psychiatric Association. 22 May 2013\. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10\.1176/appi.books.9780890425596\.dsm08](//doi.org/10.1176%2Fappi.books.9780890425596.dsm08). [ISBN](http://en.wikipedia.org/wiki/International_Standard_Book_Number "wikipedia:International Standard Book Number") [9780890425558](http://en.wikipedia.org/wiki/Special:BookSources/9780890425558 "wikipedia:Special:BookSources/9780890425558"). CS1 maint: Extra text ([link](/w/index.php?title=Category:CS1_maint:_Extra_text&action=edit&redlink=1 "Category:CS1 maint: Extra text (page does not exist)"))
9. ↑ [9\.0](#cite_ref-:6_9-0) [9\.1](#cite_ref-:6_9-1) Sierra, M., Baker, D., Medford, N., David, A. S. (October 2005\). ["Unpacking the depersonalization syndrome: an exploratory factor analysis on the Cambridge Depersonalization Scale"](https://www.cambridge.org/core/product/identifier/S0033291705005325/type/journal_article). *Psychological Medicine*. **35** (10\): 1523–1532\. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10\.1017/S0033291705005325](//doi.org/10.1017%2FS0033291705005325). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number "wikipedia:International Standard Serial Number") [0033\-2917](//www.worldcat.org/issn/0033-2917). 
10. ↑ [10\.0](#cite_ref-:8_10-0) [10\.1](#cite_ref-:8_10-1) [10\.2](#cite_ref-:8_10-2) [10\.3](#cite_ref-:8_10-3) [10\.4](#cite_ref-:8_10-4) Stein, D. J., Simeon, D. (September 2009\). ["Cognitive\-Affective Neuroscience of Depersonalization"](https://www.cambridge.org/core/product/identifier/S109285290002352X/type/journal_article). *CNS Spectrums*. **14** (9\): 467–471\. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10\.1017/S109285290002352X](//doi.org/10.1017%2FS109285290002352X). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number "wikipedia:International Standard Serial Number") [1092\-8529](//www.worldcat.org/issn/1092-8529). 
11. ↑ [11\.0](#cite_ref-:7_11-0) [11\.1](#cite_ref-:7_11-1) Mathew, R. J., Wilson, W. H., Humphreys, D., Lowe, J. V., Weithe, K. E. (March 1993\). ["Depersonalization after marijuana smoking"](https://linkinghub.elsevier.com/retrieve/pii/0006322393901719). *Biological Psychiatry*. **33** (6\): 431–441\. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10\.1016/0006\-3223(93\)90171\-9](//doi.org/10.1016%2F0006-3223%2893%2990171-9). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number "wikipedia:International Standard Serial Number") [0006\-3223](//www.worldcat.org/issn/0006-3223). 
12. [↑](#cite_ref-12) Erard, R., Luisada, P. V., Peele, R. (July 1980\). ["The PCP Psychosis: Prolonged Intoxication or Drug\-Precipitated Functional Illness?"](https://www.tandfonline.com/doi/full/10.1080/02791072.1980.10471432). *Journal of Psychedelic Drugs*. **12** (3–4\): 235–251\. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10\.1080/02791072\.1980\.10471432](//doi.org/10.1080%2F02791072.1980.10471432). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number "wikipedia:International Standard Serial Number") [0022\-393X](//www.worldcat.org/issn/0022-393X). 
13. [↑](#cite_ref-13) Pradhan, S. N. (December 1984\). ["Phencyclidine (PCP): Some human studies"](https://linkinghub.elsevier.com/retrieve/pii/014976348490006X). *Neuroscience \& Biobehavioral Reviews*. **8** (4\): 493–501\. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10\.1016/0149\-7634(84\)90006\-X](//doi.org/10.1016%2F0149-7634%2884%2990006-X). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number "wikipedia:International Standard Serial Number") [0149\-7634](//www.worldcat.org/issn/0149-7634). 
14. [↑](#cite_ref-14) Mathew, R. J., Wilson, W. H., Chiu, N. Y., Turkington, T. G., Degrado, T. R., Coleman, R. E. (July 1999\). ["Regional cerebral blood flow and depersonalization after tetrahydrocannabinol adrninistration"](https://onlinelibrary.wiley.com/doi/10.1111/j.1600-0447.1999.tb10916.x). *Acta Psychiatrica Scandinavica*. **100** (1\): 67–75\. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10\.1111/j.1600\-0447\.1999\.tb10916\.x](//doi.org/10.1111%2Fj.1600-0447.1999.tb10916.x). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number "wikipedia:International Standard Serial Number") [0001\-690X](//www.worldcat.org/issn/0001-690X). 
15. [↑](#cite_ref-15) Roy\-Byrne, P. P., Hommer, D. (June 1988\). ["Benzodiazepine withdrawal: Overview and implications for the treatment of anxiety"](https://linkinghub.elsevier.com/retrieve/pii/0002934388903099). *The American Journal of Medicine*. **84** (6\): 1041–1052\. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10\.1016/0002\-9343(88\)90309\-9](//doi.org/10.1016%2F0002-9343%2888%2990309-9). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number "wikipedia:International Standard Serial Number") [0002\-9343](//www.worldcat.org/issn/0002-9343). 
16. [↑](#cite_ref-16) Duncan, J. (September 1988\). ["Neuropsychiatric aspects of sedative drug withdrawal"](https://onlinelibrary.wiley.com/doi/10.1002/hup.470030304). *Human Psychopharmacology: Clinical and Experimental*. **3** (3\): 171–180\. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10\.1002/hup.470030304](//doi.org/10.1002%2Fhup.470030304). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number "wikipedia:International Standard Serial Number") [0885\-6222](//www.worldcat.org/issn/0885-6222). 
17. [↑](#cite_ref-17) Hunter, E. C. M., Sierra, M., David, A. S. (1 January 2004\). ["The epidemiology ofdepersonalisation and derealisation"](https://doi.org/10.1007/s00127-004-0701-4). *Social Psychiatry and Psychiatric Epidemiology*. **39** (1\): 9–18\. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10\.1007/s00127\-004\-0701\-4](//doi.org/10.1007%2Fs00127-004-0701-4). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number "wikipedia:International Standard Serial Number") [1433\-9285](//www.worldcat.org/issn/1433-9285).
